Pulmonary vascular and cardiac impairment in interstitial lung disease

Marios Panagiotou, Alistair C. Church, Martin K. Johnson, Andrew J. Peacock

Source: Eur Respir Rev 2017; 26: 160128
Journal Issue: January
Disease area: Pulmonary vascular diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Marios Panagiotou, Alistair C. Church, Martin K. Johnson, Andrew J. Peacock. Pulmonary vascular and cardiac impairment in interstitial lung disease. Eur Respir Rev 2017; 26: 160128

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Acute hyperoxic challenge improves haemodynamics & Pulmonary vascular stiffness in interstitial lung disease-associated pulmonary hypertension
Source: International Congress 2016 – Connective tissue disorders
Year: 2016

Pulmonary vascular response patterns during exercise in interstitial lung disease
Source: Eur Respir J 2015; 46: 738-749
Year: 2015



Pulmonary rehabilitation for interstitial lung disease
Source: ERS Course 2017
Year: 2017

Pulmonary rehabilitation in interstitial lung disease
Source: ERS Course 2020 - Pulmonary rehabilitation
Year: 2020


Relation between pulmonary arterial remodeling and parenchymal disease in severe COPD and interstitial lung disease patients
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014

Pulmonary hypertension in patients with interstitial lung disease
Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases
Year: 2011


Pulmonary hypertension in interstitial lung disease
Source: Eur Respir J 2008; 31: 1357-1367
Year: 2008



Pulmonary hypertension in interstitial lung diseases
Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease
Year: 2009


Pulmonary hypertensive vasculopathy in parenchymal lung diseases and/or hypoxia
Source: Eur Respir Rev, 26 (144) 170003; 10.1183/16000617.0003-2017
Year: 2017



Biomarkers for pulmonary hypertension in interstitial lung disease
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011


Biomarkers in pulmonary hypertension associated to interstitial lung disease
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010

Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity
Source: Eur Respir J 2005; 26: 586-593
Year: 2005



Pulmonary hypertension in different interstitial lung diseases
Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Year: 2012


Pulmonary function involvement in scleroderma
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013

Pulmonary vascular disease
Source: HERMES Summer School 2014 - Educational material
Year: 2014

Non-invasive haemodynamic measurement to detect treatment response in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014

Pulmonary hypertension due to lung disease
Source: International Congress 2017 – Russian Programme 2017
Year: 2017

Pulmonary artery dilation and increased lung density in systemic sclerosis
Source: International Congress 2015 – A more functional view of chest pathology
Year: 2015